SI2485724T1 - Sulfonamidi za preprečevanje diabetesa - Google Patents

Sulfonamidi za preprečevanje diabetesa

Info

Publication number
SI2485724T1
SI2485724T1 SI201031165T SI201031165T SI2485724T1 SI 2485724 T1 SI2485724 T1 SI 2485724T1 SI 201031165 T SI201031165 T SI 201031165T SI 201031165 T SI201031165 T SI 201031165T SI 2485724 T1 SI2485724 T1 SI 2485724T1
Authority
SI
Slovenia
Prior art keywords
sulfonamides
diabetes
prevention
Prior art date
Application number
SI201031165T
Other languages
English (en)
Slovenian (sl)
Inventor
Lorenzo Piemonti
Luisa Daffonchio
Marcello Allegretti
Original Assignee
Dompe farmaceutici s.p.a
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe farmaceutici s.p.a filed Critical Dompe farmaceutici s.p.a
Publication of SI2485724T1 publication Critical patent/SI2485724T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/51—Y being a hydrogen or a carbon atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SI201031165T 2009-10-06 2010-10-06 Sulfonamidi za preprečevanje diabetesa SI2485724T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09172365A EP2308485A1 (en) 2009-10-06 2009-10-06 Sulfonamides for the prevention of diabetes
EP10768898.8A EP2485724B1 (en) 2009-10-06 2010-10-06 Sulfonamides for the prevention of diabetes
PCT/EP2010/064920 WO2011042465A1 (en) 2009-10-06 2010-10-06 Sulfonamides for the prevention of diabetes

Publications (1)

Publication Number Publication Date
SI2485724T1 true SI2485724T1 (sl) 2018-12-31

Family

ID=41716341

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201031165T SI2485724T1 (sl) 2009-10-06 2010-10-06 Sulfonamidi za preprečevanje diabetesa

Country Status (24)

Country Link
US (2) US8846755B2 (enExample)
EP (2) EP2308485A1 (enExample)
JP (1) JP5745526B2 (enExample)
KR (1) KR101737656B1 (enExample)
CN (1) CN102639128B (enExample)
AU (1) AU2010305384B2 (enExample)
BR (1) BR112012007989B1 (enExample)
CA (1) CA2776021C (enExample)
CY (1) CY1117599T1 (enExample)
DK (1) DK2485724T3 (enExample)
EA (1) EA021788B1 (enExample)
ES (1) ES2570463T3 (enExample)
HR (1) HRP20160399T1 (enExample)
HU (1) HUE028132T2 (enExample)
IL (1) IL219038A (enExample)
ME (1) ME02385B (enExample)
MX (1) MX2012004087A (enExample)
NZ (1) NZ599171A (enExample)
PL (1) PL2485724T3 (enExample)
RS (1) RS54693B1 (enExample)
SI (1) SI2485724T1 (enExample)
SM (1) SMT201600126B (enExample)
WO (1) WO2011042465A1 (enExample)
ZA (1) ZA201202462B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
EP2308485A1 (en) 2009-10-06 2011-04-13 Dompé S.p.a. Sulfonamides for the prevention of diabetes
EP3281937A1 (en) * 2016-08-09 2018-02-14 Dompé farmaceutici S.p.A. Sulfonamides as gpr40- and gpr120-agonists
WO2018067548A1 (en) 2016-10-03 2018-04-12 The Children's Medicial Center Corporation Prevention and treatment of diabetic nephropathy
EP4686469A1 (en) 2024-07-31 2026-02-04 Dompé farmaceutici SpA Cxcl8 inhibitors for use in the treatment of diabetes-associated comorbidities

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1303249B1 (it) 1998-10-23 2000-11-06 Dompe Spa Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
ITMI20010206A1 (it) * 2001-02-02 2002-08-02 Dompe Spa Uso della metansolfonammide di (r)-ibuprofene e dei suoi sali non tossici per la preparazione di medicamenti per il trattamento e la prevenz
US20040242498A1 (en) * 2003-02-27 2004-12-02 Collins Tassie L. CXCR3 antagonists
HRP20090681T1 (hr) 2004-03-23 2010-02-28 Dompe' S.P.A. Derivati 2-fenilpropionske kiseline i farmaceutski pripravci koji ih sadrže
DE602004003673T2 (de) 2004-03-25 2007-10-04 Dompe' Pha.R.Ma S.P.A. Verwendung von N-(2-Aryl-propionyl)-sulfonamiden zur Behandlung von Rückenmarkverletzungen
KR20110014141A (ko) * 2008-03-20 2011-02-10 카롤러스 테라퓨틱스, 인코포레이티드 염증을 치료하는 방법
EP2308484A1 (en) * 2009-10-06 2011-04-13 Dompé S.p.a. Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets
EP2308485A1 (en) 2009-10-06 2011-04-13 Dompé S.p.a. Sulfonamides for the prevention of diabetes

Also Published As

Publication number Publication date
PL2485724T3 (pl) 2016-07-29
BR112012007989B1 (pt) 2019-10-22
KR101737656B1 (ko) 2017-05-18
NZ599171A (en) 2014-03-28
AU2010305384A1 (en) 2012-04-26
CA2776021C (en) 2017-08-01
ES2570463T3 (es) 2016-05-18
ZA201202462B (en) 2013-06-26
US20150011639A1 (en) 2015-01-08
US20130059908A1 (en) 2013-03-07
ME02385B (me) 2016-09-20
CA2776021A1 (en) 2011-04-14
US8846755B2 (en) 2014-09-30
US9556115B2 (en) 2017-01-31
EP2485724B1 (en) 2016-02-10
DK2485724T3 (en) 2016-05-02
RS54693B1 (sr) 2016-08-31
CN102639128A (zh) 2012-08-15
IL219038A (en) 2015-07-30
JP2013506703A (ja) 2013-02-28
KR20120083889A (ko) 2012-07-26
SMT201600126B (it) 2016-07-01
AU2010305384B2 (en) 2016-02-04
EA021788B1 (ru) 2015-08-31
EA201270512A1 (ru) 2012-11-30
EP2308485A1 (en) 2011-04-13
CY1117599T1 (el) 2017-04-26
CN102639128B (zh) 2014-02-26
EP2485724A1 (en) 2012-08-15
WO2011042465A1 (en) 2011-04-14
JP5745526B2 (ja) 2015-07-08
HRP20160399T1 (hr) 2016-05-20
HUE028132T2 (en) 2016-11-28
MX2012004087A (es) 2012-08-23
IL219038A0 (en) 2012-06-28
HK1174557A1 (en) 2013-06-14

Similar Documents

Publication Publication Date Title
GB0907425D0 (en) Compounds
EP2393493A4 (en) LINKS
PL2385938T3 (pl) Pochodne sulfonamidu
GB0907515D0 (en) Compounds
GB0914856D0 (en) Compounds
GB0905641D0 (en) Compounds
GB0909671D0 (en) Compounds
IL219038A0 (en) Sulfonamides for the prevention of diabetes
EP2507737A4 (en) ATTACHING FUNCTIONS NOT EXPORTED BY SHIFTING A FUNCTION
GB0909672D0 (en) Compounds
AP2909A (en) Pyrazinoisoquinoline Compounds
GB0911000D0 (en) Compounds
EP2443115A4 (en) COMPOUNDS
ZA201109204B (en) Processes for the preparation of sevelamer carbonate
GB0913313D0 (en) Modified microplate
GB0918825D0 (en) Tab
GB0904311D0 (en) Processes for the preparation of compounds
GB0908941D0 (en) Compounds
GB0906853D0 (en) Compounds
GB0913248D0 (en) Compounds
GB0910008D0 (en) Compounds
GB0908942D0 (en) Compounds
GB0902156D0 (en) Compounds
GB0909912D0 (en) Compounds
GB0906854D0 (en) Compounds